Literature DB >> 9751695

What else can the immune system recognize?

D Izhaky1, I Pecht.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9751695      PMCID： PMC33900          DOI： 10.1073/pnas.95.20.11509

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  11 in total

Review 1.  Biological applications of fullerenes.

Authors:  A W Jensen; S R Wilson; D I Schuster
Journal:  Bioorg Med Chem       Date:  1996-06       Impact factor: 3.641

2.  Monoclonal antibody recognition of cholesterol monohydrate crystal faces.

Authors:  D Perl-Treves; N Kessler; D Izhaky; L Addadi
Journal:  Chem Biol       Date:  1996-07

3.  Monoclonal antibodies that specifically recognize crystals of dinitrobenzene.

Authors:  N Kessler; D Perl-Treves; L Addadi
Journal:  FASEB J       Date:  1996-10       Impact factor: 5.191

Review 4.  T cell-independent antigens type 2.

Authors:  J J Mond; A Lees; C M Snapper
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

5.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution.

Authors:  J N Varghese; W G Laver; P M Colman
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

6.  Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.

Authors:  B X Chen; S R Wilson; M Das; D J Coughlin; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Antibodies to liposomes, phospholipids and phosphate esters.

Authors:  C R Alving
Journal:  Chem Phys Lipids       Date:  1986 Jun-Jul       Impact factor: 3.329

8.  Antibodies to cholesterol.

Authors:  G M Swartz; M K Gentry; L M Amende; E J Blanchette-Mackie; C R Alving
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

Review 9.  Interactions of protein antigens with antibodies.

Authors:  D R Davies; G H Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

10.  THE MANUFACTURE OF ANTIBODIES IN VITRO.

Authors:  L Pauling; D H Campbell
Journal:  J Exp Med       Date:  1942-08-01       Impact factor: 14.307
View more
  6 in total

1.  Proteomic analysis of early response lymph node proteins in mice treated with titanium dioxide nanoparticles.

Authors:  Yuan Gao; Neera V Gopee; Paul C Howard; Li-Rong Yu
Journal:  J Proteomics       Date:  2011-08-22       Impact factor: 4.044

Review 2.  Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?

Authors:  Peter Hoet; Barbara Legiest; Jorina Geys; Benoit Nemery
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.

Authors:  Marina A Dobrovolskaia; Scott E McNeil
Journal:  J Control Release       Date:  2013-06-03       Impact factor: 9.776

4.  Development and characterization of antibody reagents for detecting nanoparticles.

Authors:  Supriya Ravichandran; Mark A Sullivan; Linda M Callahan; Karen L Bentley; Lisa A DeLouise
Journal:  Nanoscale       Date:  2015-11-16       Impact factor: 7.790

Review 5.  Hide and Seek: Nanomaterial Interactions With the Immune System.

Authors:  Bengt Fadeel
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

6.  Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential.

Authors:  Haibin Luo; Yuling Li; David Robbins; Sheau-Chiann Wang; Guoling Xi; Matthew Cox; Simone M Nicholson; Chenghong Wei; Timothy M Pabst; William K Wang
Journal:  Biotechnol Prog       Date:  2021-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.